# Yext timeline

entity: /record/yext.md  
id: ent_yext  


## undated

- undated | listed_on | NYSE | valid | [clm_2B58315BB9B4](/claim/clm_2B58315BB9B4.md)
- undated | registrant_name | Yext, Inc. | valid | [clm_4D25811FE788](/claim/clm_4D25811FE788.md)
- undated | cik | 0001614178 | valid | [clm_950A24563548](/claim/clm_950A24563548.md)
- undated | state_of_incorporation | DE | valid | [clm_99974C061C3F](/claim/clm_99974C061C3F.md)
- undated | sic_industry | Services-Computer Processing & Data Preparation (7374) | valid | [clm_AAE1E70D6713](/claim/clm_AAE1E70D6713.md)
- undated | fiscal_year_end | 01-31 | valid | [clm_B42C98E26145](/claim/clm_B42C98E26145.md)
- undated | ticker | YEXT | valid | [clm_BB56111A0BEE](/claim/clm_BB56111A0BEE.md)
- undated | legal_form | joint-stock company | unverified | [clm_DFECD484A56E](/claim/clm_DFECD484A56E.md)
- undated | website | http://yext.com | unverified | [clm_F8413F917239](/claim/clm_F8413F917239.md)

## 2009

- 2009-05-19 | x_username | yext | unverified | [clm_E75434CD02BC](/claim/clm_E75434CD02BC.md)

## 2015

- 2015-01-31 to 2016-01-31 | cash_and_equivalents | 48,952,000 United States dollar | superseded | [clm_23D098BEBF50](/claim/clm_23D098BEBF50.md)
- 2015-01-31 to 2016-01-31 | total_equity | -74,435,000 United States dollar | superseded | [clm_EE80EEF941FD](/claim/clm_EE80EEF941FD.md)

## 2016

- 2016-01-31 to 2017-01-31 | revenue | 89,724,000 United States dollar | superseded | [clm_155953DC4269](/claim/clm_155953DC4269.md)
- 2016-01-31 to 2017-01-31 | net_income | -26,495,000 United States dollar | superseded | [clm_27FDC9D857AA](/claim/clm_27FDC9D857AA.md)
- 2016-01-31 to 2016-04-30 | cash_and_equivalents | 30,028,000 United States dollar | superseded | [clm_5BE41407AB56](/claim/clm_5BE41407AB56.md)
- 2016-01-31 to 2017-01-31 | total_equity | -95,236,000 United States dollar | superseded | [clm_B31C442C5765](/claim/clm_B31C442C5765.md)
- 2016-01-31 to 2017-01-31 | research_and_development | 16,201,000 United States dollar | superseded | [clm_B560052598B4](/claim/clm_B560052598B4.md)
- 2016-01-31 to 2017-01-31 | operating_income | -26,138,000 United States dollar | superseded | [clm_B86EBF1A8038](/claim/clm_B86EBF1A8038.md)
- 2016-04-30 to 2016-07-31 | quarterly_net_income | -9,343,000 United States dollar | superseded | [clm_1EA6DA1E13CA](/claim/clm_1EA6DA1E13CA.md)
- 2016-04-30 to 2016-07-31 | cash_and_equivalents | 37,055,000 United States dollar | superseded | [clm_42072342DB3C](/claim/clm_42072342DB3C.md)
- 2016-04-30 to 2016-07-31 | quarterly_revenue | 27,125,000 United States dollar | superseded | [clm_517CA54EA002](/claim/clm_517CA54EA002.md)
- 2016-04-30 to 2016-07-31 | quarterly_operating_income | -9,307,000 United States dollar | superseded | [clm_7A735E06315B](/claim/clm_7A735E06315B.md)
- 2016-04-30 to 2016-07-31 | quarterly_research_and_development | 4,771,000 United States dollar | superseded | [clm_F717B0D3CFB1](/claim/clm_F717B0D3CFB1.md)
- 2016-07-31 to 2016-10-31 | quarterly_net_income | -9,012,000 United States dollar | superseded | [clm_1AF3CD8829FA](/claim/clm_1AF3CD8829FA.md)
- 2016-07-31 to 2016-10-31 | quarterly_revenue | 29,556,000 United States dollar | superseded | [clm_1DF4AA74AE74](/claim/clm_1DF4AA74AE74.md)
- 2016-07-31 to 2016-10-31 | quarterly_operating_income | -9,007,000 United States dollar | superseded | [clm_26AE185FEB9A](/claim/clm_26AE185FEB9A.md)
- 2016-07-31 to 2016-10-31 | quarterly_research_and_development | 4,673,000 United States dollar | superseded | [clm_BDC76A6E1C02](/claim/clm_BDC76A6E1C02.md)
- 2016-07-31 to 2016-10-31 | cash_and_equivalents | 30,708,000 United States dollar | superseded | [clm_D76A741675A8](/claim/clm_D76A741675A8.md)
- 2016-10-31 to 2017-01-31 | cash_and_equivalents | 20,728,000 United States dollar | superseded | [clm_0642FFB87D6B](/claim/clm_0642FFB87D6B.md)
- 2016-10-31 to 2017-04-30 | quarterly_revenue | 31,909,000 United States dollar | superseded | [clm_8BF82C1D44BD](/claim/clm_8BF82C1D44BD.md)
- 2016-10-31 to 2017-04-30 | quarterly_net_income | -10,222,000 United States dollar | superseded | [clm_8C88941CC99D](/claim/clm_8C88941CC99D.md)
- 2016-10-31 to 2017-04-30 | quarterly_research_and_development | 4,764,000 United States dollar | superseded | [clm_8E6107E6502B](/claim/clm_8E6107E6502B.md)
- 2016-10-31 to 2017-04-30 | quarterly_operating_income | -10,120,000 United States dollar | superseded | [clm_9373AE65CFBA](/claim/clm_9373AE65CFBA.md)

## 2017

- 2017-01-31 to 2017-04-30 | cash_and_equivalents | 24,420,000 United States dollar | superseded | [clm_0044C1230716](/claim/clm_0044C1230716.md)
- 2017-01-31 to 2018-01-31 | research_and_development | 19,316,000 United States dollar | superseded | [clm_1A5C3271665A](/claim/clm_1A5C3271665A.md)
- 2017-01-31 to 2018-01-31 | net_income | -43,150,000 United States dollar | superseded | [clm_1A6769AC91E8](/claim/clm_1A6769AC91E8.md)
- 2017-01-31 to 2018-01-31 | operating_income | -42,700,000 United States dollar | superseded | [clm_69DDA159117E](/claim/clm_69DDA159117E.md)
- 2017-01-31 to 2017-04-30 | total_assets | 86,465,000 United States dollar | superseded | [clm_723376F93A1D](/claim/clm_723376F93A1D.md)
- 2017-01-31 to 2018-01-31 | revenue | 124,261,000 United States dollar | superseded | [clm_A14A5B14CB74](/claim/clm_A14A5B14CB74.md)
- 2017-01-31 to 2017-04-30 | total_equity | -127,755,000 United States dollar | superseded | [clm_C3147348BE55](/claim/clm_C3147348BE55.md)
- 2017-04-30 to 2017-07-31 | total_assets | 186,652,000 United States dollar | superseded | [clm_0428B4F7C5C6](/claim/clm_0428B4F7C5C6.md)
- 2017-04-30 to 2017-07-31 | quarterly_operating_income | -15,394,000 United States dollar | superseded | [clm_087A9ED4EA32](/claim/clm_087A9ED4EA32.md)
- 2017-04-30 to 2017-07-31 | quarterly_research_and_development | 4,986,000 United States dollar | superseded | [clm_870F6E37404A](/claim/clm_870F6E37404A.md)
- 2017-04-30 to 2017-07-31 | quarterly_net_income | -16,106,000 United States dollar | superseded | [clm_A346CAC1316E](/claim/clm_A346CAC1316E.md)
- 2017-04-30 to 2017-07-31 | total_equity | 103,677,000 United States dollar | superseded | [clm_DA4238394C6A](/claim/clm_DA4238394C6A.md)
- 2017-04-30 to 2017-07-31 | quarterly_revenue | 37,080,000 United States dollar | superseded | [clm_EDE675C58049](/claim/clm_EDE675C58049.md)
- 2017-04-30 to 2017-07-31 | cash_and_equivalents | 133,735,000 United States dollar | superseded | [clm_F5C44FEDB9D4](/claim/clm_F5C44FEDB9D4.md)
- 2017-05-30 to 2017-08-29 | shares_outstanding | 90,041,408 shares | superseded | [clm_B07563453D3E](/claim/clm_B07563453D3E.md)
- 2017-07-31 to 2017-10-31 | quarterly_net_income | -16,399,000 United States dollar | superseded | [clm_5B37BE8D98B4](/claim/clm_5B37BE8D98B4.md)
- 2017-07-31 to 2017-10-31 | quarterly_revenue | 40,769,000 United States dollar | superseded | [clm_625224672DD5](/claim/clm_625224672DD5.md)
- 2017-07-31 to 2017-10-31 | quarterly_operating_income | -16,507,000 United States dollar | superseded | [clm_8ED4CD3D7FF7](/claim/clm_8ED4CD3D7FF7.md)
- 2017-07-31 to 2017-10-31 | total_assets | 176,589,000 United States dollar | superseded | [clm_9541960F600E](/claim/clm_9541960F600E.md)
- 2017-07-31 to 2017-10-31 | quarterly_research_and_development | 6,493,000 United States dollar | superseded | [clm_A01601D65114](/claim/clm_A01601D65114.md)
- 2017-07-31 to 2017-10-31 | total_equity | 92,884,000 United States dollar | superseded | [clm_C195AA29EDD9](/claim/clm_C195AA29EDD9.md)
- 2017-07-31 to 2017-10-31 | cash_and_equivalents | 32,879,000 United States dollar | superseded | [clm_E4E2A1DFCB59](/claim/clm_E4E2A1DFCB59.md)
- 2017-08-29 to 2017-11-27 | shares_outstanding | 90,236,332 shares | superseded | [clm_9FB49C2DF361](/claim/clm_9FB49C2DF361.md)
- 2017-10-31 to 2018-04-30 | quarterly_operating_income | -17,236,000 United States dollar | superseded | [clm_079BBC704330](/claim/clm_079BBC704330.md)
- 2017-10-31 to 2018-01-31 | total_equity | 84,125,000 United States dollar | superseded | [clm_8C83C979B53A](/claim/clm_8C83C979B53A.md)
- 2017-10-31 to 2018-01-31 | cash_and_equivalents | 21,112,000 United States dollar | superseded | [clm_968943E3E925](/claim/clm_968943E3E925.md)
- 2017-10-31 to 2018-01-31 | total_assets | 171,917,000 United States dollar | superseded | [clm_9B667F34AC7E](/claim/clm_9B667F34AC7E.md)
- 2017-10-31 to 2018-04-30 | quarterly_revenue | 44,332,000 United States dollar | superseded | [clm_A0B65AA72927](/claim/clm_A0B65AA72927.md)
- 2017-10-31 to 2018-04-30 | quarterly_net_income | -17,062,000 United States dollar | superseded | [clm_D5CFA4157AA5](/claim/clm_D5CFA4157AA5.md)
- 2017-10-31 to 2018-04-30 | quarterly_research_and_development | 6,958,000 United States dollar | superseded | [clm_EA5F402D9C37](/claim/clm_EA5F402D9C37.md)
- 2017-11-27 to 2018-02-28 | shares_outstanding | 91,230,806 shares | superseded | [clm_B0F210F15253](/claim/clm_B0F210F15253.md)

## 2018

- 2018-01-31 to 2019-01-31 | research_and_development | 25,687,000 United States dollar | superseded | [clm_15BEC969319D](/claim/clm_15BEC969319D.md)
- 2018-01-31 to 2019-01-31 | net_income | -66,565,000 United States dollar | superseded | [clm_169D9034421C](/claim/clm_169D9034421C.md)
- 2018-01-31 to 2019-01-31 | revenue | 170,201,000 United States dollar | superseded | [clm_54D0C73B6201](/claim/clm_54D0C73B6201.md)
- 2018-01-31 to 2019-01-31 | operating_income | -66,640,000 United States dollar | superseded | [clm_570476612258](/claim/clm_570476612258.md)
- 2018-01-31 to 2018-04-30 | total_equity | 81,453,000 United States dollar | superseded | [clm_70391A883536](/claim/clm_70391A883536.md)
- 2018-01-31 to 2018-04-30 | cash_and_equivalents | 34,367,000 United States dollar | superseded | [clm_CBABDFE73F32](/claim/clm_CBABDFE73F32.md)
- 2018-01-31 to 2018-04-30 | total_assets | 203,489,000 United States dollar | superseded | [clm_DD449130AE2E](/claim/clm_DD449130AE2E.md)
- 2018-02-28 to 2018-05-23 | shares_outstanding | 94,174,107 shares | superseded | [clm_708BD49FAE1E](/claim/clm_708BD49FAE1E.md)
- 2018-04-30 to 2018-07-31 | total_assets | 188,406,000 United States dollar | superseded | [clm_319BAD232402](/claim/clm_319BAD232402.md)
- 2018-04-30 to 2018-07-31 | total_equity | 80,289,000 United States dollar | superseded | [clm_5EDBF4DCFB5B](/claim/clm_5EDBF4DCFB5B.md)
- 2018-04-30 to 2018-07-31 | quarterly_net_income | -18,136,000 United States dollar | superseded | [clm_6FDF05BA930E](/claim/clm_6FDF05BA930E.md)
- 2018-04-30 to 2018-07-31 | quarterly_revenue | 51,095,000 United States dollar | superseded | [clm_74562F6D983A](/claim/clm_74562F6D983A.md)
- 2018-04-30 to 2018-07-31 | quarterly_operating_income | -18,001,000 United States dollar | superseded | [clm_B632BCD0A967](/claim/clm_B632BCD0A967.md)
- 2018-04-30 to 2018-07-31 | quarterly_research_and_development | 7,729,000 United States dollar | superseded | [clm_D44E13117A12](/claim/clm_D44E13117A12.md)
- 2018-04-30 to 2018-07-31 | cash_and_equivalents | 53,403,000 United States dollar | superseded | [clm_F46BE9C5E1AD](/claim/clm_F46BE9C5E1AD.md)
- 2018-05-23 to 2018-08-20 | shares_outstanding | 96,842,651 shares | superseded | [clm_9A053D8801A1](/claim/clm_9A053D8801A1.md)
- 2018-07-31 to 2018-10-31 | total_assets | 197,734,000 United States dollar | superseded | [clm_25F8722C0315](/claim/clm_25F8722C0315.md)
- 2018-07-31 to 2018-10-31 | quarterly_net_income | -21,096,000 United States dollar | superseded | [clm_5C31ADC5411D](/claim/clm_5C31ADC5411D.md)
- 2018-07-31 to 2018-10-31 | cash_and_equivalents | 47,155,000 United States dollar | superseded | [clm_891D0CA29CB7](/claim/clm_891D0CA29CB7.md)
- 2018-07-31 to 2018-10-31 | total_equity | 75,608,000 United States dollar | superseded | [clm_9E3C4E2E9563](/claim/clm_9E3C4E2E9563.md)
- 2018-07-31 to 2018-10-31 | quarterly_research_and_development | 9,983,000 United States dollar | superseded | [clm_BF3100209807](/claim/clm_BF3100209807.md)
- 2018-07-31 to 2018-10-31 | quarterly_revenue | 55,096,000 United States dollar | superseded | [clm_CE7D88547BE2](/claim/clm_CE7D88547BE2.md)
- 2018-07-31 to 2018-10-31 | quarterly_operating_income | -21,204,000 United States dollar | superseded | [clm_D676BD39F98E](/claim/clm_D676BD39F98E.md)
- 2018-08-20 to 2018-11-19 | shares_outstanding | 98,585,370 shares | superseded | [clm_AEC91417EDF5](/claim/clm_AEC91417EDF5.md)
- 2018-10-31 to 2019-04-30 | quarterly_revenue | 58,742,000 United States dollar | superseded | [clm_539FA46344A3](/claim/clm_539FA46344A3.md)
- 2018-10-31 to 2019-04-30 | quarterly_net_income | -24,766,000 United States dollar | superseded | [clm_54AE1A464FB2](/claim/clm_54AE1A464FB2.md)
- 2018-10-31 to 2019-04-30 | quarterly_research_and_development | 9,158,000 United States dollar | superseded | [clm_84C25FC912FE](/claim/clm_84C25FC912FE.md)
- 2018-10-31 to 2019-04-30 | quarterly_operating_income | -24,838,000 United States dollar | superseded | [clm_AADC9AE9F32D](/claim/clm_AADC9AE9F32D.md)
- 2018-10-31 to 2019-01-31 | total_assets | 186,262,000 United States dollar | superseded | [clm_B3862B9FD96A](/claim/clm_B3862B9FD96A.md)
- 2018-10-31 to 2019-01-31 | total_equity | 71,870,000 United States dollar | superseded | [clm_C53492BB28AA](/claim/clm_C53492BB28AA.md)
- 2018-10-31 to 2019-01-31 | cash_and_equivalents | 28,337,000 United States dollar | superseded | [clm_FC5BB82D4965](/claim/clm_FC5BB82D4965.md)
- 2018-11-19 to 2019-02-28 | shares_outstanding | 100,864,546 shares | superseded | [clm_8E525F3E70AA](/claim/clm_8E525F3E70AA.md)

## 2019

- 2019-01-31 to 2020-01-31 | operating_income | -75,645,000 United States dollar | superseded | [clm_17D38E7DDD81](/claim/clm_17D38E7DDD81.md)
- 2019-01-31 to 2020-01-31 | revenue | 228,283,000 United States dollar | superseded | [clm_3E2A8921C55F](/claim/clm_3E2A8921C55F.md)
- 2019-01-31 to 2019-04-30 | total_equity | 84,549,000 United States dollar | superseded | [clm_401603C5E15C](/claim/clm_401603C5E15C.md)
- 2019-01-31 to 2019-04-30 | total_assets | 267,128,000 United States dollar | superseded | [clm_79FB057C8E65](/claim/clm_79FB057C8E65.md)
- 2019-01-31 to 2020-01-31 | research_and_development | 36,098,000 United States dollar | superseded | [clm_80CD6084E9EF](/claim/clm_80CD6084E9EF.md)
- 2019-01-31 to 2020-01-31 | net_income | -74,837,000 United States dollar | superseded | [clm_AC96DF3FDC45](/claim/clm_AC96DF3FDC45.md)
- 2019-01-31 to 2019-04-30 | cash_and_equivalents | 91,755,000 United States dollar | superseded | [clm_BD31222DB4D9](/claim/clm_BD31222DB4D9.md)
- 2019-02-28 to 2019-05-20 | shares_outstanding | 102,247,841 shares | superseded | [clm_843CCB7FB66F](/claim/clm_843CCB7FB66F.md)
- 2019-04-30 to 2019-07-31 | cash_and_equivalents | 257,663,000 United States dollar | superseded | [clm_073CB639846D](/claim/clm_073CB639846D.md)
- 2019-04-30 to 2019-07-31 | quarterly_net_income | -18,959,000 United States dollar | superseded | [clm_18C11B26C0EA](/claim/clm_18C11B26C0EA.md)
- 2019-04-30 to 2019-07-31 | total_assets | 433,298,000 United States dollar | superseded | [clm_4CBE78E36D89](/claim/clm_4CBE78E36D89.md)
- 2019-04-30 to 2019-07-31 | total_equity | 234,160,000 United States dollar | superseded | [clm_96F4776AB5D7](/claim/clm_96F4776AB5D7.md)
- 2019-04-30 to 2019-07-31 | quarterly_revenue | 68,708,000 United States dollar | superseded | [clm_BEFE5FA9BACA](/claim/clm_BEFE5FA9BACA.md)
- 2019-04-30 to 2019-07-31 | quarterly_operating_income | -19,260,000 United States dollar | superseded | [clm_D20032C4EF91](/claim/clm_D20032C4EF91.md)
- 2019-04-30 to 2019-07-31 | quarterly_research_and_development | 9,906,000 United States dollar | superseded | [clm_F1DA938CDAE6](/claim/clm_F1DA938CDAE6.md)
- 2019-05-20 to 2019-08-19 | shares_outstanding | 111,111,216 shares | superseded | [clm_56988A21188A](/claim/clm_56988A21188A.md)
- 2019-07-31 to 2019-10-31 | total_assets | 508,153,000 United States dollar | superseded | [clm_58E64A03D2BB](/claim/clm_58E64A03D2BB.md)
- 2019-07-31 to 2019-10-31 | quarterly_net_income | -29,291,000 United States dollar | superseded | [clm_79B53BCDFA91](/claim/clm_79B53BCDFA91.md)
- 2019-07-31 to 2019-10-31 | quarterly_revenue | 72,373,000 United States dollar | superseded | [clm_9C6630AE369C](/claim/clm_9C6630AE369C.md)
- 2019-07-31 to 2019-10-31 | cash_and_equivalents | 268,801,000 United States dollar | superseded | [clm_A0478DE0FC54](/claim/clm_A0478DE0FC54.md)
- 2019-07-31 to 2019-10-31 | quarterly_operating_income | -30,297,000 United States dollar | superseded | [clm_A55032F6ED8A](/claim/clm_A55032F6ED8A.md)
- 2019-07-31 to 2019-10-31 | total_equity | 225,139,000 United States dollar | superseded | [clm_E7D50B97D038](/claim/clm_E7D50B97D038.md)
- 2019-07-31 to 2019-10-31 | quarterly_research_and_development | 12,686,000 United States dollar | superseded | [clm_ED79DE63370D](/claim/clm_ED79DE63370D.md)
- 2019-08-19 to 2019-11-25 | shares_outstanding | 112,753,106 shares | superseded | [clm_9A671148FAA7](/claim/clm_9A671148FAA7.md)
- 2019-10-31 to 2020-01-31 | total_assets | 485,762,000 United States dollar | superseded | [clm_08BDCD7E9909](/claim/clm_08BDCD7E9909.md)
- 2019-10-31 to 2020-04-30 | quarterly_net_income | -42,717,000 United States dollar | superseded | [clm_2B29568153E3](/claim/clm_2B29568153E3.md)
- 2019-10-31 to 2020-01-31 | cash_and_equivalents | 244,754,000 United States dollar | superseded | [clm_553DE4DF96F0](/claim/clm_553DE4DF96F0.md)
- 2019-10-31 to 2020-04-30 | quarterly_revenue | 76,370,000 United States dollar | superseded | [clm_D21D5557F85C](/claim/clm_D21D5557F85C.md)
- 2019-10-31 to 2020-04-30 | quarterly_research_and_development | 13,011,000 United States dollar | superseded | [clm_E2922BFACA2A](/claim/clm_E2922BFACA2A.md)
- 2019-10-31 to 2020-04-30 | quarterly_operating_income | -42,833,000 United States dollar | superseded | [clm_EFD7E86D82E9](/claim/clm_EFD7E86D82E9.md)
- 2019-10-31 to 2020-01-31 | total_equity | 212,356,000 United States dollar | superseded | [clm_F08D646E5770](/claim/clm_F08D646E5770.md)
- 2019-11-25 to 2020-03-02 | shares_outstanding | 114,812,626 shares | superseded | [clm_01A531D767F3](/claim/clm_01A531D767F3.md)

## 2020

- 2020-01-31 to 2020-04-30 | total_assets | 563,620,000 United States dollar | superseded | [clm_030AE78029BF](/claim/clm_030AE78029BF.md)
- 2020-01-31 to 2020-04-30 | cash_and_equivalents | 256,076,000 United States dollar | superseded | [clm_10C23701D01A](/claim/clm_10C23701D01A.md)
- 2020-01-31 to 2021-01-31 | net_income | -121,544,000 United States dollar | superseded | [clm_26D2C8481FAB](/claim/clm_26D2C8481FAB.md)
- 2020-01-31 to 2021-01-31 | operating_income | -122,953,000 United States dollar | superseded | [clm_8F38979021C9](/claim/clm_8F38979021C9.md)
- 2020-01-31 to 2021-01-31 | revenue | 298,829,000 United States dollar | superseded | [clm_AC16C0D03525](/claim/clm_AC16C0D03525.md)
- 2020-01-31 to 2021-01-31 | research_and_development | 49,445,000 United States dollar | superseded | [clm_BCD24CCEBEA5](/claim/clm_BCD24CCEBEA5.md)
- 2020-01-31 to 2020-04-30 | total_equity | 201,212,000 United States dollar | superseded | [clm_C51DE492D942](/claim/clm_C51DE492D942.md)
- 2020-03-02 to 2020-06-01 | shares_outstanding | 115,847,791 shares | superseded | [clm_0F8101D17851](/claim/clm_0F8101D17851.md)
- 2020-04-30 to 2020-07-31 | total_equity | 193,911,000 United States dollar | superseded | [clm_0329012D1D81](/claim/clm_0329012D1D81.md)
- 2020-04-30 to 2020-07-31 | quarterly_revenue | 85,351,000 United States dollar | superseded | [clm_38918B21DB9D](/claim/clm_38918B21DB9D.md)
- 2020-04-30 to 2020-07-31 | quarterly_net_income | -29,224,000 United States dollar | superseded | [clm_7FD8FBA8F1D6](/claim/clm_7FD8FBA8F1D6.md)
- 2020-04-30 to 2020-07-31 | total_assets | 536,790,000 United States dollar | superseded | [clm_81795B0D2695](/claim/clm_81795B0D2695.md)
- 2020-04-30 to 2020-07-31 | quarterly_operating_income | -29,189,000 United States dollar | superseded | [clm_E488EAC3ED7E](/claim/clm_E488EAC3ED7E.md)
- 2020-04-30 to 2020-07-31 | cash_and_equivalents | 248,796,000 United States dollar | superseded | [clm_EA5AC7725F68](/claim/clm_EA5AC7725F68.md)
- 2020-04-30 to 2020-07-31 | quarterly_research_and_development | 14,378,000 United States dollar | superseded | [clm_FB82F609B3F4](/claim/clm_FB82F609B3F4.md)
- 2020-06-01 to 2020-08-24 | shares_outstanding | 117,723,196 shares | superseded | [clm_4EB417922B15](/claim/clm_4EB417922B15.md)
- 2020-07-31 to 2020-10-31 | total_assets | 531,656,000 United States dollar | superseded | [clm_031AF6346CFF](/claim/clm_031AF6346CFF.md)
- 2020-07-31 to 2020-10-31 | cash_and_equivalents | 223,347,000 United States dollar | superseded | [clm_0A6CE1C8B256](/claim/clm_0A6CE1C8B256.md)
- 2020-07-31 to 2020-10-31 | quarterly_operating_income | -24,240,000 United States dollar | superseded | [clm_18A7FEF05289](/claim/clm_18A7FEF05289.md)
- 2020-07-31 to 2020-10-31 | quarterly_research_and_development | 14,788,000 United States dollar | superseded | [clm_5054AA8764CF](/claim/clm_5054AA8764CF.md)
- 2020-07-31 to 2020-10-31 | quarterly_net_income | -25,116,000 United States dollar | superseded | [clm_8FF42F9625EA](/claim/clm_8FF42F9625EA.md)
- 2020-07-31 to 2020-10-31 | total_equity | 193,548,000 United States dollar | superseded | [clm_C324ADC877AE](/claim/clm_C324ADC877AE.md)
- 2020-07-31 to 2020-10-31 | quarterly_revenue | 88,055,000 United States dollar | superseded | [clm_EA13E431AE69](/claim/clm_EA13E431AE69.md)
- 2020-08-24 to 2020-11-23 | shares_outstanding | 119,611,368 shares | superseded | [clm_3F8B0280000C](/claim/clm_3F8B0280000C.md)
- 2020-10-31 to 2021-01-31 | total_equity | 200,663,000 United States dollar | superseded | [clm_28F079080662](/claim/clm_28F079080662.md)
- 2020-10-31 to 2021-04-30 | quarterly_revenue | 89,061,000 United States dollar | superseded | [clm_3CCAB42C5BDC](/claim/clm_3CCAB42C5BDC.md)
- 2020-10-31 to 2021-01-31 | total_assets | 514,941,000 United States dollar | superseded | [clm_42EBB4187190](/claim/clm_42EBB4187190.md)
- 2020-10-31 to 2021-04-30 | quarterly_net_income | -22,041,000 United States dollar | superseded | [clm_4BBBB8A059F9](/claim/clm_4BBBB8A059F9.md)
- 2020-10-31 to 2021-01-31 | cash_and_equivalents | 208,996,000 United States dollar | superseded | [clm_6CD206ADD5BB](/claim/clm_6CD206ADD5BB.md)
- 2020-10-31 to 2021-04-30 | quarterly_research_and_development | 14,475,000 United States dollar | superseded | [clm_7EE3433A7D36](/claim/clm_7EE3433A7D36.md)
- 2020-10-31 to 2021-04-30 | quarterly_operating_income | -21,760,000 United States dollar | superseded | [clm_C33051E9D149](/claim/clm_C33051E9D149.md)
- 2020-11-23 to 2021-03-01 | shares_outstanding | 122,266,596 shares | superseded | [clm_EE9259A79C5B](/claim/clm_EE9259A79C5B.md)

## 2021

- 2021-01-31 to 2022-01-31 | operating_income | -94,332,000 United States dollar | superseded | [clm_09E28B0FF2F3](/claim/clm_09E28B0FF2F3.md)
- 2021-01-31 to 2022-01-31 | revenue | 354,661,000 United States dollar | superseded | [clm_3649119ACA73](/claim/clm_3649119ACA73.md)
- 2021-01-31 to 2021-04-30 | total_assets | 595,989,000 United States dollar | superseded | [clm_377030AB8A38](/claim/clm_377030AB8A38.md)
- 2021-01-31 to 2022-01-31 | research_and_development | 58,146,000 United States dollar | superseded | [clm_63F6C0916AB0](/claim/clm_63F6C0916AB0.md)
- 2021-01-31 to 2021-04-30 | total_equity | 207,235,000 United States dollar | superseded | [clm_8A3B49B224AB](/claim/clm_8A3B49B224AB.md)
- 2021-01-31 to 2021-04-30 | cash_and_equivalents | 230,411,000 United States dollar | superseded | [clm_B74F68A181EC](/claim/clm_B74F68A181EC.md)
- 2021-01-31 to 2022-01-31 | net_income | -94,692,000 United States dollar | superseded | [clm_EC61C0BDC3FF](/claim/clm_EC61C0BDC3FF.md)
- 2021-03-01 to 2021-05-24 | shares_outstanding | 124,807,360 shares | superseded | [clm_C1A5C74B8A56](/claim/clm_C1A5C74B8A56.md)
- 2021-04-30 to 2021-07-31 | total_assets | 598,673,000 United States dollar | superseded | [clm_4A60B85D40C0](/claim/clm_4A60B85D40C0.md)
- 2021-04-30 to 2021-07-31 | cash_and_equivalents | 272,099,000 United States dollar | superseded | [clm_4DB589CDAE52](/claim/clm_4DB589CDAE52.md)
- 2021-04-30 to 2021-07-31 | quarterly_research_and_development | 13,857,000 United States dollar | superseded | [clm_7591CDFB3A35](/claim/clm_7591CDFB3A35.md)
- 2021-04-30 to 2021-07-31 | quarterly_revenue | 91,992,000 United States dollar | superseded | [clm_776F77550D02](/claim/clm_776F77550D02.md)
- 2021-04-30 to 2021-07-31 | quarterly_operating_income | -17,232,000 United States dollar | superseded | [clm_79B4B53A0E2E](/claim/clm_79B4B53A0E2E.md)
- 2021-04-30 to 2021-07-31 | quarterly_net_income | -17,631,000 United States dollar | superseded | [clm_7EBEE457F224](/claim/clm_7EBEE457F224.md)
- 2021-04-30 to 2021-07-31 | total_equity | 221,175,000 United States dollar | superseded | [clm_8D33220D004F](/claim/clm_8D33220D004F.md)
- 2021-05-24 to 2021-08-23 | shares_outstanding | 126,243,515 shares | superseded | [clm_3F45EB9F0611](/claim/clm_3F45EB9F0611.md)
- 2021-07-31 to 2021-10-31 | quarterly_revenue | 98,124,000 United States dollar | superseded | [clm_37CA83B8CD7F](/claim/clm_37CA83B8CD7F.md)
- 2021-07-31 to 2021-10-31 | quarterly_net_income | -27,592,000 United States dollar | superseded | [clm_6428A367A746](/claim/clm_6428A367A746.md)
- 2021-07-31 to 2021-10-31 | quarterly_operating_income | -26,412,000 United States dollar | superseded | [clm_650ECAB11E9B](/claim/clm_650ECAB11E9B.md)
- 2021-07-31 to 2021-10-31 | quarterly_research_and_development | 18,500,000 United States dollar | superseded | [clm_75D1126BCA72](/claim/clm_75D1126BCA72.md)
- 2021-07-31 to 2021-10-31 | total_assets | 568,744,000 United States dollar | superseded | [clm_B25EA7F2B993](/claim/clm_B25EA7F2B993.md)
- 2021-07-31 to 2021-10-31 | total_equity | 216,579,000 United States dollar | superseded | [clm_BA6F95AB809A](/claim/clm_BA6F95AB809A.md)
- 2021-07-31 to 2021-10-31 | cash_and_equivalents | 240,490,000 United States dollar | superseded | [clm_EC7DD38EE462](/claim/clm_EC7DD38EE462.md)
- 2021-08-23 to 2021-11-23 | shares_outstanding | 127,845,122 shares | superseded | [clm_DBE52CFE9B0A](/claim/clm_DBE52CFE9B0A.md)
- 2021-10-31 to 2022-04-30 | quarterly_operating_income | -24,354,000 United States dollar | superseded | [clm_012B60B18D25](/claim/clm_012B60B18D25.md)
- 2021-10-31 to 2022-01-31 | total_equity | 215,013,000 United States dollar | superseded | [clm_089125E9AEDC](/claim/clm_089125E9AEDC.md)
- 2021-10-31 to 2022-01-31 | cash_and_equivalents | 229,526,000 United States dollar | superseded | [clm_266A26592509](/claim/clm_266A26592509.md)
- 2021-10-31 to 2022-04-30 | quarterly_research_and_development | 17,986,000 United States dollar | superseded | [clm_3059CE2AEF3A](/claim/clm_3059CE2AEF3A.md)
- 2021-10-31 to 2022-04-30 | quarterly_revenue | 99,529,000 United States dollar | superseded | [clm_9161CA76DC58](/claim/clm_9161CA76DC58.md)
- 2021-10-31 to 2022-01-31 | total_assets | 556,205,000 United States dollar | superseded | [clm_AAF88726A3F4](/claim/clm_AAF88726A3F4.md)
- 2021-10-31 to 2022-04-30 | quarterly_net_income | -24,926,000 United States dollar | superseded | [clm_D88961EB28AA](/claim/clm_D88961EB28AA.md)
- 2021-11-23 to 2022-03-01 | shares_outstanding | 129,703,118 shares | superseded | [clm_C997E2C01209](/claim/clm_C997E2C01209.md)

## 2022

- 2022-01-31 to 2022-04-30 | cash_and_equivalents | 261,210,000 United States dollar | superseded | [clm_0306B2D5F6D6](/claim/clm_0306B2D5F6D6.md)
- 2022-01-31 to 2023-01-31 | net_income | -93,259,000 United States dollar | superseded | [clm_67B40E5410B4](/claim/clm_67B40E5410B4.md)
- 2022-01-31 to 2022-04-30 | total_assets | 620,335,000 United States dollar | superseded | [clm_7F64AEF0D0C8](/claim/clm_7F64AEF0D0C8.md)
- 2022-01-31 to 2022-04-30 | total_equity | 211,870,000 United States dollar | superseded | [clm_81A60BE3B8AF](/claim/clm_81A60BE3B8AF.md)
- 2022-01-31 to 2023-01-31 | research_and_development | 68,350,000 United States dollar | superseded | [clm_91866EADDAEF](/claim/clm_91866EADDAEF.md)
- 2022-01-31 to 2023-01-31 | revenue | 390,577,000 United States dollar | superseded | [clm_E4732CEE33EF](/claim/clm_E4732CEE33EF.md)
- 2022-01-31 to 2023-01-31 | operating_income | -89,959,000 United States dollar | superseded | [clm_EA1F423EDB13](/claim/clm_EA1F423EDB13.md)
- 2022-03-01 to 2022-05-25 | shares_outstanding | 131,186,882 shares | superseded | [clm_D1D33B889EAD](/claim/clm_D1D33B889EAD.md)
- 2022-04-30 to 2022-07-31 | total_assets | 555,434,000 United States dollar | superseded | [clm_35336A4A8A24](/claim/clm_35336A4A8A24.md)
- 2022-04-30 to 2022-07-31 | quarterly_operating_income | -25,502,000 United States dollar | superseded | [clm_6954FD5A40FA](/claim/clm_6954FD5A40FA.md)
- 2022-04-30 to 2022-07-31 | quarterly_net_income | -25,839,000 United States dollar | superseded | [clm_DE9D0CC40E2C](/claim/clm_DE9D0CC40E2C.md)
- 2022-04-30 to 2022-07-31 | quarterly_research_and_development | 17,302,000 United States dollar | superseded | [clm_E2F04C9303B6](/claim/clm_E2F04C9303B6.md)
- 2022-04-30 to 2022-07-31 | cash_and_equivalents | 247,769,000 United States dollar | superseded | [clm_EE0432546079](/claim/clm_EE0432546079.md)
- 2022-04-30 to 2022-07-31 | total_equity | 172,920,000 United States dollar | superseded | [clm_EFA9E56D046D](/claim/clm_EFA9E56D046D.md)
- 2022-04-30 to 2022-07-31 | quarterly_revenue | 98,802,000 United States dollar | superseded | [clm_FE269454B705](/claim/clm_FE269454B705.md)
- 2022-05-25 to 2022-08-24 | shares_outstanding | 123,588,182 shares | superseded | [clm_33637D20D693](/claim/clm_33637D20D693.md)
- 2022-07-31 to 2022-10-31 | quarterly_revenue | 100,869,000 United States dollar | superseded | [clm_34712AE187E8](/claim/clm_34712AE187E8.md)
- 2022-07-31 to 2022-10-31 | total_assets | 480,324,000 United States dollar | superseded | [clm_4395A8CE97A9](/claim/clm_4395A8CE97A9.md)
- 2022-07-31 to 2022-10-31 | quarterly_net_income | -19,991,000 United States dollar | superseded | [clm_477ADB6FA3B5](/claim/clm_477ADB6FA3B5.md)
- 2022-07-31 to 2022-10-31 | total_equity | 138,946,000 United States dollar | superseded | [clm_6F3E2C60C108](/claim/clm_6F3E2C60C108.md)
- 2022-07-31 to 2022-10-31 | quarterly_operating_income | -19,521,000 United States dollar | superseded | [clm_749D43E44EE2](/claim/clm_749D43E44EE2.md)
- 2022-07-31 to 2022-10-31 | cash_and_equivalents | 187,906,000 United States dollar | superseded | [clm_7F2EF1CAC061](/claim/clm_7F2EF1CAC061.md)
- 2022-07-31 to 2022-10-31 | quarterly_research_and_development | 18,819,000 United States dollar | superseded | [clm_BE0F9E1CE6AB](/claim/clm_BE0F9E1CE6AB.md)
- 2022-08-24 to 2022-11-23 | shares_outstanding | 123,435,932 shares | superseded | [clm_7DBE55A373BC](/claim/clm_7DBE55A373BC.md)
- 2022-10-31 to 2023-01-31 | cash_and_equivalents | 162,268,000 United States dollar | superseded | [clm_01147B131FB6](/claim/clm_01147B131FB6.md)
- 2022-10-31 to 2023-01-31 | total_equity | 129,851,000 United States dollar | superseded | [clm_100CEBF94DF2](/claim/clm_100CEBF94DF2.md)
- 2022-10-31 to 2023-01-31 | total_assets | 456,106,000 United States dollar | superseded | [clm_1201A3A3124E](/claim/clm_1201A3A3124E.md)
- 2022-10-31 to 2023-04-30 | quarterly_operating_income | -12,132,000 United States dollar | superseded | [clm_384AD6BE9F1F](/claim/clm_384AD6BE9F1F.md)
- 2022-10-31 to 2023-04-30 | quarterly_revenue | 99,280,000 United States dollar | superseded | [clm_3B24F1A1401F](/claim/clm_3B24F1A1401F.md)
- 2022-10-31 to 2023-04-30 | quarterly_research_and_development | 17,649,000 United States dollar | superseded | [clm_6B2182268956](/claim/clm_6B2182268956.md)
- 2022-10-31 to 2023-04-30 | quarterly_net_income | -12,310,000 United States dollar | superseded | [clm_EBE75C35FECD](/claim/clm_EBE75C35FECD.md)
- 2022-11-23 to 2023-03-01 | shares_outstanding | 122,098,247 shares | superseded | [clm_4995E2A783FD](/claim/clm_4995E2A783FD.md)

## 2023

- 2023-01-31 to 2023-04-30 | total_assets | 523,761,000 United States dollar | superseded | [clm_141F0C3C1CE5](/claim/clm_141F0C3C1CE5.md)
- 2023-01-31 to 2024-01-31 | research_and_development | 70,903,000 United States dollar | superseded | [clm_260D2AB30B4E](/claim/clm_260D2AB30B4E.md)
- 2023-01-31 to 2023-04-30 | cash_and_equivalents | 190,214,000 United States dollar | superseded | [clm_4BD911F7EBFA](/claim/clm_4BD911F7EBFA.md)
- 2023-01-31 to 2024-01-31 | operating_income | -64,828,000 United States dollar | superseded | [clm_6C618C8DB556](/claim/clm_6C618C8DB556.md)
- 2023-01-31 to 2024-01-31 | net_income | -65,938,000 United States dollar | superseded | [clm_91C6FE878B3D](/claim/clm_91C6FE878B3D.md)
- 2023-01-31 to 2024-01-31 | revenue | 400,850,000 United States dollar | superseded | [clm_DEB4F06DC3E9](/claim/clm_DEB4F06DC3E9.md)
- 2023-01-31 to 2023-04-30 | total_equity | 128,023,000 United States dollar | superseded | [clm_E8541289CA5D](/claim/clm_E8541289CA5D.md)
- 2023-03-01 to 2023-05-25 | shares_outstanding | 122,104,719 shares | superseded | [clm_6EEF2341DAE0](/claim/clm_6EEF2341DAE0.md)
- 2023-04-30 to 2023-07-31 | quarterly_revenue | 99,453,000 United States dollar | superseded | [clm_65DE71429F22](/claim/clm_65DE71429F22.md)
- 2023-04-30 to 2023-07-31 | quarterly_net_income | -412,000 United States dollar | superseded | [clm_671537E6800A](/claim/clm_671537E6800A.md)
- 2023-04-30 to 2023-07-31 | total_assets | 488,792,000 United States dollar | superseded | [clm_94286E41F1E1](/claim/clm_94286E41F1E1.md)
- 2023-04-30 to 2023-07-31 | quarterly_research_and_development | 16,753,000 United States dollar | superseded | [clm_AB0D07118827](/claim/clm_AB0D07118827.md)
- 2023-04-30 to 2023-07-31 | total_equity | 140,587,000 United States dollar | superseded | [clm_B45A00DDCDF2](/claim/clm_B45A00DDCDF2.md)
- 2023-04-30 to 2023-07-31 | quarterly_operating_income | -1,232,000 United States dollar | superseded | [clm_CC07C65BDAE7](/claim/clm_CC07C65BDAE7.md)
- 2023-04-30 to 2023-07-31 | cash_and_equivalents | 216,850,000 United States dollar | superseded | [clm_F7C903616EAB](/claim/clm_F7C903616EAB.md)
- 2023-05-25 to 2023-08-24 | shares_outstanding | 124,029,157 shares | superseded | [clm_6EB3F1E8F991](/claim/clm_6EB3F1E8F991.md)
- 2023-07-31 to 2023-10-31 | cash_and_equivalents | 200,527,000 United States dollar | superseded | [clm_0B8AC53070E8](/claim/clm_0B8AC53070E8.md)
- 2023-07-31 to 2023-10-31 | total_assets | 459,352,000 United States dollar | superseded | [clm_18B75AC40992](/claim/clm_18B75AC40992.md)
- 2023-07-31 to 2023-10-31 | quarterly_operating_income | -4,231,000 United States dollar | superseded | [clm_22AD4AAFF065](/claim/clm_22AD4AAFF065.md)
- 2023-07-31 to 2023-10-31 | total_equity | 139,021,000 United States dollar | superseded | [clm_2303D6F86F4E](/claim/clm_2303D6F86F4E.md)
- 2023-07-31 to 2023-10-31 | quarterly_research_and_development | 18,890,000 United States dollar | superseded | [clm_7C157F3E274C](/claim/clm_7C157F3E274C.md)
- 2023-07-31 to 2023-10-31 | quarterly_revenue | 102,598,000 United States dollar | superseded | [clm_7C4F1465F3D0](/claim/clm_7C4F1465F3D0.md)
- 2023-07-31 to 2023-10-31 | quarterly_net_income | -3,437,000 United States dollar | superseded | [clm_89A92AC6BD6F](/claim/clm_89A92AC6BD6F.md)
- 2023-08-24 to 2023-11-21 | shares_outstanding | 124,483,298 shares | superseded | [clm_F7AD7EB5BC27](/claim/clm_F7AD7EB5BC27.md)
- 2023-10-31 to 2024-04-30 | quarterly_net_income | -468,000 United States dollar | superseded | [clm_25F1DDD9EE9C](/claim/clm_25F1DDD9EE9C.md)
- 2023-10-31 to 2024-01-31 | cash_and_equivalents | 182,156,000 United States dollar | superseded | [clm_3C79F27AF2B6](/claim/clm_3C79F27AF2B6.md)
- 2023-10-31 to 2024-04-30 | quarterly_operating_income | -1,781,000 United States dollar | superseded | [clm_9565A68BBFB5](/claim/clm_9565A68BBFB5.md)
- 2023-10-31 to 2024-04-30 | quarterly_research_and_development | 18,291,000 United States dollar | superseded | [clm_996593E250B7](/claim/clm_996593E250B7.md)
- 2023-10-31 to 2024-01-31 | total_assets | 431,640,000 United States dollar | superseded | [clm_9B78594950E1](/claim/clm_9B78594950E1.md)
- 2023-10-31 to 2024-01-31 | total_equity | 136,346,000 United States dollar | superseded | [clm_F80AF3F44046](/claim/clm_F80AF3F44046.md)
- 2023-10-31 to 2024-04-30 | quarterly_revenue | 101,164,000 United States dollar | superseded | [clm_F9D1E022026D](/claim/clm_F9D1E022026D.md)
- 2023-11-21 to 2024-02-28 | shares_outstanding | 124,073,118 shares | superseded | [clm_D9FB7FBFC175](/claim/clm_D9FB7FBFC175.md)

## 2024

- 2024-01-31 to 2025-01-31 | revenue | 404,322,000 United States dollar | superseded | [clm_0B020410305B](/claim/clm_0B020410305B.md)
- 2024-01-31 to 2024-04-30 | total_equity | 147,174,000 United States dollar | superseded | [clm_8D60709F16AD](/claim/clm_8D60709F16AD.md)
- 2024-01-31 to 2024-04-30 | cash_and_equivalents | 210,184,000 United States dollar | superseded | [clm_B3544ED69F93](/claim/clm_B3544ED69F93.md)
- 2024-01-31 to 2025-01-31 | research_and_development | 72,040,000 United States dollar | superseded | [clm_EB790776BDC1](/claim/clm_EB790776BDC1.md)
- 2024-01-31 to 2025-01-31 | operating_income | -6,201,000 United States dollar | superseded | [clm_EFF35AC954BC](/claim/clm_EFF35AC954BC.md)
- 2024-01-31 to 2025-01-31 | net_income | -2,630,000 United States dollar | superseded | [clm_F0CC9C84B546](/claim/clm_F0CC9C84B546.md)
- 2024-01-31 to 2024-04-30 | total_assets | 508,810,000 United States dollar | superseded | [clm_FEF86983DEC0](/claim/clm_FEF86983DEC0.md)
- 2024-02-28 to 2024-05-28 | shares_outstanding | 124,867,093 shares | superseded | [clm_99164D1F53A2](/claim/clm_99164D1F53A2.md)
- 2024-04-30 to 2024-07-31 | quarterly_operating_income | -5,426,000 United States dollar | superseded | [clm_0789C9930E27](/claim/clm_0789C9930E27.md)
- 2024-04-30 to 2024-07-31 | quarterly_revenue | 95,990,000 United States dollar | superseded | [clm_235D5437BE60](/claim/clm_235D5437BE60.md)
- 2024-04-30 to 2024-07-31 | total_assets | 481,730,000 United States dollar | superseded | [clm_41997367C39E](/claim/clm_41997367C39E.md)
- 2024-04-30 to 2024-07-31 | quarterly_research_and_development | 17,059,000 United States dollar | superseded | [clm_4CCE49776CB0](/claim/clm_4CCE49776CB0.md)
- 2024-04-30 to 2024-07-31 | quarterly_net_income | -3,817,000 United States dollar | superseded | [clm_6DC8432D48E6](/claim/clm_6DC8432D48E6.md)
- 2024-04-30 to 2024-07-31 | cash_and_equivalents | 246,114,000 United States dollar | superseded | [clm_A480EA40ADED](/claim/clm_A480EA40ADED.md)
- 2024-04-30 to 2024-07-31 | total_equity | 155,674,000 United States dollar | superseded | [clm_D5619F3EFBBD](/claim/clm_D5619F3EFBBD.md)
- 2024-05-28 to 2024-08-21 | shares_outstanding | 126,139,075 shares | superseded | [clm_F52EB172051B](/claim/clm_F52EB172051B.md)
- 2024-07-31 to 2024-10-31 | total_assets | 458,204,000 United States dollar | superseded | [clm_1546A9814649](/claim/clm_1546A9814649.md)
- 2024-07-31 to 2024-10-31 | quarterly_revenue | 97,887,000 United States dollar | superseded | [clm_4BF6F4725498](/claim/clm_4BF6F4725498.md)
- 2024-07-31 to 2024-10-31 | total_equity | 162,803,000 United States dollar | superseded | [clm_623F9C72F69C](/claim/clm_623F9C72F69C.md)
- 2024-07-31 to 2024-10-31 | quarterly_net_income | -4,057,000 United States dollar | superseded | [clm_83A3D0B43E75](/claim/clm_83A3D0B43E75.md)
- 2024-07-31 to 2024-10-31 | quarterly_research_and_development | 18,580,000 United States dollar | superseded | [clm_8E9DB80B1770](/claim/clm_8E9DB80B1770.md)
- 2024-07-31 to 2024-10-31 | quarterly_operating_income | -7,566,000 United States dollar | superseded | [clm_8FC12AACDFD5](/claim/clm_8FC12AACDFD5.md)
- 2024-07-31 to 2024-10-31 | cash_and_equivalents | 234,823,000 United States dollar | superseded | [clm_F536943537A0](/claim/clm_F536943537A0.md)
- 2024-08-21 to 2024-11-25 | shares_outstanding | 127,920,766 shares | superseded | [clm_ED74204416EC](/claim/clm_ED74204416EC.md)
- 2024-10-31 to 2025-01-31 | cash_and_equivalents | 100,484,000 United States dollar | superseded | [clm_120E8D790B4B](/claim/clm_120E8D790B4B.md)
- 2024-10-31 to 2025-04-30 | quarterly_revenue | 113,989,000 United States dollar | superseded | [clm_5A08F9AC9C67](/claim/clm_5A08F9AC9C67.md)
- 2024-10-31 to 2025-04-30 | quarterly_net_income | -12,799,000 United States dollar | superseded | [clm_72D5CBFD235D](/claim/clm_72D5CBFD235D.md)
- 2024-10-31 to 2025-04-30 | quarterly_operating_income | -10,368,000 United States dollar | superseded | [clm_9366E1DC8CED](/claim/clm_9366E1DC8CED.md)
- 2024-10-31 to 2025-01-31 | total_equity | 159,962,000 United States dollar | superseded | [clm_A35BB28CF0C3](/claim/clm_A35BB28CF0C3.md)
- 2024-10-31 to 2025-01-31 | total_assets | 540,343,000 United States dollar | superseded | [clm_B7B815BC9D51](/claim/clm_B7B815BC9D51.md)
- 2024-10-31 to 2025-04-30 | quarterly_research_and_development | 21,070,000 United States dollar | superseded | [clm_C74D07B5B4F2](/claim/clm_C74D07B5B4F2.md)
- 2024-11-25 to 2025-02-26 | shares_outstanding | 127,621,329 shares | superseded | [clm_D106F9EA892D](/claim/clm_D106F9EA892D.md)

## 2025

- 2025-01-31 to 2026-01-31 | net_income | -27,948,000 United States dollar | superseded | [clm_1ECC863765BD](/claim/clm_1ECC863765BD.md)
- 2025-01-31 to 2026-01-31 | research_and_development | 77,201,000 United States dollar | superseded | [clm_1F2CE0879EC7](/claim/clm_1F2CE0879EC7.md)
- 2025-01-31 to 2025-04-30 | total_equity | 153,193,000 United States dollar | superseded | [clm_825A5BDCC994](/claim/clm_825A5BDCC994.md)
- 2025-01-31 to 2025-04-30 | cash_and_equivalents | 123,133,000 United States dollar | superseded | [clm_B7BC48E81240](/claim/clm_B7BC48E81240.md)
- 2025-01-31 to 2025-04-30 | total_assets | 610,078,000 United States dollar | superseded | [clm_CD68339D450B](/claim/clm_CD68339D450B.md)
- 2025-01-31 to 2026-01-31 | operating_income | -32,448,000 United States dollar | superseded | [clm_E8B4C695314F](/claim/clm_E8B4C695314F.md)
- 2025-01-31 to 2026-01-31 | revenue | 420,957,000 United States dollar | superseded | [clm_F1ACE9A185F7](/claim/clm_F1ACE9A185F7.md)
- 2025-02-07 | agreement | KabanaSoft, LLC d/b/a Places Scout | valid | [clm_32DEA78465CD](/claim/clm_32DEA78465CD.md)
- 2025-02-26 to 2025-05-27 | shares_outstanding | 126,484,781 shares | superseded | [clm_49FC681B517A](/claim/clm_49FC681B517A.md)
- 2025-04-30 to 2025-07-31 | quarterly_operating_income | 1,118,000 United States dollar | superseded | [clm_05C4724B9E54](/claim/clm_05C4724B9E54.md)
- 2025-04-30 to 2025-07-31 | quarterly_net_income | 770,000 United States dollar | superseded | [clm_3AA68A5340E9](/claim/clm_3AA68A5340E9.md)
- 2025-04-30 to 2025-07-31 | cash_and_equivalents | 114,994,000 United States dollar | superseded | [clm_475E3E584E9E](/claim/clm_475E3E584E9E.md)
- 2025-04-30 to 2025-07-31 | total_equity | 142,025,000 United States dollar | superseded | [clm_5717D61EC9E5](/claim/clm_5717D61EC9E5.md)
- 2025-04-30 to 2025-07-31 | total_assets | 572,356,000 United States dollar | superseded | [clm_A9CCED1C1FFE](/claim/clm_A9CCED1C1FFE.md)
- 2025-04-30 to 2025-07-31 | quarterly_research_and_development | 21,896,000 United States dollar | superseded | [clm_FB72F92572D5](/claim/clm_FB72F92572D5.md)
- 2025-04-30 to 2025-07-31 | quarterly_revenue | 109,483,000 United States dollar | superseded | [clm_FFAE10277A27](/claim/clm_FFAE10277A27.md)
- 2025-05-27 to 2025-08-20 | shares_outstanding | 122,397,716 shares | superseded | [clm_F5128624D5A5](/claim/clm_F5128624D5A5.md)
- 2025-07-31 to 2025-10-31 | quarterly_research_and_development | 23,352,000 United States dollar | superseded | [clm_2F776C513F9F](/claim/clm_2F776C513F9F.md)
- 2025-07-31 to 2025-10-31 | quarterly_revenue | 113,094,000 United States dollar | superseded | [clm_7AAF877CBA3F](/claim/clm_7AAF877CBA3F.md)
- 2025-07-31 to 2025-10-31 | total_assets | 626,166,000 United States dollar | superseded | [clm_872041DDEA57](/claim/clm_872041DDEA57.md)
- 2025-07-31 to 2025-10-31 | quarterly_operating_income | 29,674,000 United States dollar | superseded | [clm_982F8CF3D1C8](/claim/clm_982F8CF3D1C8.md)
- 2025-07-31 to 2025-10-31 | quarterly_net_income | 26,751,000 United States dollar | superseded | [clm_9EEADA653D98](/claim/clm_9EEADA653D98.md)
- 2025-07-31 to 2025-10-31 | cash_and_equivalents | 178,761,000 United States dollar | superseded | [clm_A395D6C5707E](/claim/clm_A395D6C5707E.md)
- 2025-07-31 to 2025-10-31 | total_equity | 152,529,000 United States dollar | superseded | [clm_D0EB334A5275](/claim/clm_D0EB334A5275.md)
- 2025-08-20 to 2025-11-24 | shares_outstanding | 123,236,797 shares | superseded | [clm_1302CE67660B](/claim/clm_1302CE67660B.md)
- 2025-10-31 to 2026-04-30 | quarterly_operating_income | 7,780,000 United States dollar | superseded | [clm_30818A5866AF](/claim/clm_30818A5866AF.md)
- 2025-10-31 to 2026-01-31 | total_equity | 155,172,000 United States dollar | superseded | [clm_352DE8F808DF](/claim/clm_352DE8F808DF.md)
- 2025-10-31 to 2026-01-31 | total_assets | 555,773,000 United States dollar | superseded | [clm_91FC3179BE7D](/claim/clm_91FC3179BE7D.md)
- 2025-10-31 to 2026-04-30 | quarterly_revenue | 111,998,000 United States dollar | superseded | [clm_9D3CB31AD500](/claim/clm_9D3CB31AD500.md)
- 2025-10-31 to 2026-04-30 | quarterly_net_income | 6,136,000 United States dollar | superseded | [clm_BA1ED8631EA4](/claim/clm_BA1ED8631EA4.md)
- 2025-10-31 to 2026-04-30 | quarterly_research_and_development | 22,614,000 United States dollar | superseded | [clm_C5E760133036](/claim/clm_C5E760133036.md)
- 2025-10-31 to 2026-01-31 | cash_and_equivalents | 139,916,000 United States dollar | superseded | [clm_F66BBA4978BA](/claim/clm_F66BBA4978BA.md)
- 2025-11-24 to 2026-02-23 | shares_outstanding | 122,626,997 shares | superseded | [clm_A01B21A79DA5](/claim/clm_A01B21A79DA5.md)

## 2026

- 2026-01-31 | revenue | 446,579,000 United States dollar | valid | [clm_151A0D6B8996](/claim/clm_151A0D6B8996.md)
- 2026-01-31 to 2026-04-30 | total_assets | 621,776,000 United States dollar | superseded | [clm_18392C5B09FB](/claim/clm_18392C5B09FB.md)
- 2026-01-31 to 2026-04-30 | cash_and_equivalents | 154,123,000 United States dollar | superseded | [clm_2AEEEDC0F796](/claim/clm_2AEEEDC0F796.md)
- 2026-01-31 | operating_income | 44,549,000 United States dollar | valid | [clm_49655197F6A6](/claim/clm_49655197F6A6.md)
- 2026-01-31 | net_income | 37,871,000 United States dollar | valid | [clm_9F1EA3AE7FFC](/claim/clm_9F1EA3AE7FFC.md)
- 2026-01-31 to 2026-04-30 | total_equity | 159,421,000 United States dollar | superseded | [clm_AFF864127E65](/claim/clm_AFF864127E65.md)
- 2026-01-31 | research_and_development | 89,874,000 United States dollar | valid | [clm_DE82B344610E](/claim/clm_DE82B344610E.md)
- 2026-02-23 to 2026-05-19 | shares_outstanding | 123,345,128 shares | superseded | [clm_53094698335E](/claim/clm_53094698335E.md)
- 2026-04-30 to 2026-07-31 | quarterly_research_and_development | 21,480,000 United States dollar | superseded | [clm_3385DE33525D](/claim/clm_3385DE33525D.md)
- 2026-04-30 to 2026-07-31 | quarterly_revenue | 107,917,000 United States dollar | superseded | [clm_626A0C9F7171](/claim/clm_626A0C9F7171.md)
- 2026-04-30 to 2026-07-31 | cash_and_equivalents | 91,881,000 United States dollar | superseded | [clm_760E22E0CB34](/claim/clm_760E22E0CB34.md)
- 2026-04-30 to 2026-07-31 | total_assets | 499,484,000 United States dollar | superseded | [clm_998E51037DD6](/claim/clm_998E51037DD6.md)
- 2026-04-30 to 2026-07-31 | quarterly_net_income | 2,625,000 United States dollar | superseded | [clm_C78036CA2445](/claim/clm_C78036CA2445.md)
- 2026-04-30 to 2026-07-31 | quarterly_operating_income | 5,582,000 United States dollar | superseded | [clm_D2792B888961](/claim/clm_D2792B888961.md)
- 2026-04-30 to 2026-07-31 | total_equity | 24,479,000 United States dollar | superseded | [clm_FBDC61D30ECF](/claim/clm_FBDC61D30ECF.md)
- 2026-05-19 to 2026-08-18 | shares_outstanding | 100,248,116 shares | superseded | [clm_22F17A34161F](/claim/clm_22F17A34161F.md)
- 2026-07-07 | board_member | Cynthia Paul | valid | [clm_5F75428D2CCD](/claim/clm_5F75428D2CCD.md)
- 2026-07-31 | quarterly_operating_income | 17,562,000 United States dollar | valid | [clm_54EDF43CE417](/claim/clm_54EDF43CE417.md)
- 2026-07-31 | quarterly_net_income | 13,149,000 United States dollar | valid | [clm_6E3631E8D9D8](/claim/clm_6E3631E8D9D8.md)
- 2026-07-31 | total_equity | 35,662,000 United States dollar | valid | [clm_86DAAA042B14](/claim/clm_86DAAA042B14.md)
- 2026-07-31 | total_assets | 483,947,000 United States dollar | valid | [clm_89E4F73643FE](/claim/clm_89E4F73643FE.md)
- 2026-07-31 | quarterly_revenue | 111,103,000 United States dollar | valid | [clm_8FEECC71A9E5](/claim/clm_8FEECC71A9E5.md)
- 2026-07-31 | cash_and_equivalents | 86,828,000 United States dollar | valid | [clm_BCC2A9FE0D6A](/claim/clm_BCC2A9FE0D6A.md)
- 2026-07-31 | quarterly_research_and_development | 19,373,000 United States dollar | valid | [clm_BE8EE20A6448](/claim/clm_BE8EE20A6448.md)
- 2026-08-18 | shares_outstanding | 98,978,704 shares | valid | [clm_DAC5584ADCB3](/claim/clm_DAC5584ADCB3.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.